Glaxo Faces Amended Suit Over HIV Drugs
October 16, 2002
GlaxoSmithKline is facing new allegations in an antitrust lawsuit that AIDS Healthcare Foundation filed in Los Angeles in July, challenging the lack of generic competition for the company's two HIV drugs. The foundation alleges that Glaxo lied to the US Patent and Trademark Office when it sought a patent on Retrovir, known as AZT and a key ingredient in both drugs. The lawsuit says Glaxo did not invent AZT nor did it conduct the research showing AZT's use in fighting HIV. "We never claimed to have invented AZT," said a Glaxo spokesperson. Scientists with a Glaxo predecessor "identified its use in the treatment of AIDS."
Los Angeles Times
10.15.02; Bloomberg News
This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. Visit the CDC's website to find out more about their activities, publications and services.